Stents Drug Eluting

Medtronic, CE Mark, Resolute Onyx DES, drug-eluting stent, expanded sizes and indications
News | Stents Drug Eluting | February 02, 2016
February 2, 2016 — Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the...
News | Stents Drug Eluting | January 08, 2016
January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient...
Blog | Cath Lab | November 05, 2015
For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...
Videos | TCT | November 05, 2015
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies...
Videos | TCT | November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...
News | Stents Bioresorbable | October 30, 2015
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable...
Absorb II, Absorb stent, bioresorbable stents, TCT 2015
News | Stents Bioresorbable | October 30, 2015
October 30, 2015 – Two-year follow-up data from the first randomized study comparing the Absorb everolimus-eluting...
Videos | Stents Drug Eluting | October 30, 2015
Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide...
Videos | Stents Bioresorbable | October 30, 2015
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for...
News | Stents Drug Eluting | October 27, 2015
October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA...
REMEDEE Registry, one-year outcomes, Combo dual therapy stent, OrbusNeich, TCT 2015
News | Stents Drug Eluting | October 26, 2015
October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient...
TUXEDO trial, diabetic patients, drug-eluting stents, everolimus, paclitaxel, TCT 2015

Image courtesy of Abbott Vascular

News | Stents Drug Eluting | October 23, 2015
October 23, 2015 — Results of the TUXEDO...
ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a...
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...
Amaranth Medical Bioresorbable Scaffold, Fortitude stent
News | Stents Bioresorbable | October 16, 2015
October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials...
Overlay Init